Reader Feedback Survey

Facebook

X

Email

Previous articleFully defined 3D culture substrate for cancer research

distinctive

READ THE LATEST ISSUE

Huge advances have been made in our understanding of neurodegenerative diseases – but ALS still has no cure and new investment is urgently needed, shares Dr Amanda Cole, Director, @OHENews.

🔗 Read more: https://www.biosciencetoday.co.uk/successful-als-treatments-are-a-143bn-opportunity-to-change-lives/

#DrugDiscovery #ALS

Reply on Twitter 2044347552145801604 Retweet on Twitter 2044347552145801604 Like on Twitter 2044347552145801604 Twitter 2044347552145801604

Bioscience Today @biosciencetoday ·

14 Apr

How can we explain the onset of psychotic symptoms characteristic of schizophrenia? A team from @unige_en provides new insight into this question.

🧠 Read more:

#MentalHealth #Neuroscience

Reply on Twitter 2044022916036133080 Retweet on Twitter 2044022916036133080 Like on Twitter 2044022916036133080 2 Twitter 2044022916036133080

Bioscience Today @biosciencetoday ·

13 Apr

The breakthrough – by biotech @basecamp_res – aims to tackle a longstanding challenge in genetic medicine by developing a new generation of curative cell & gene therapies.

🧬 Read more:

#ArtificialIntelligence #Therapeutics

Reply on Twitter 2043713366716187029 Retweet on Twitter 2043713366716187029 Like on Twitter 2043713366716187029 Twitter 2043713366716187029

ABOUT US

Bioscience Today (previously Bioscience Journal) is a contemporary publication with the goal of making the UK Life Sciences sector a focal point for clinical research and medical innovation.

Contact us: info@biosciencetoday.co.uk

ABOUT US

FOLLOW US